CoChat

Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway

Open access

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

Cellular glycosphingolipid (GSL) storage is known to promote cholesterol accumulation. Although physical interactions between GSLs and cholesterol are thought to cause intracellular cholesterol "trapping," it is not known whether cholesterol homeostatic mechanisms are also impaired under these conditions. ApoA-I-mediated cholesterol efflux via ABCA1 (ATP-binding cassette transporter A1) is a key regulator of cellular cholesterol balance. Here, we show that apoA-I-mediated cholesterol efflux was inhibited (by up to 53% over 8 h) when fibroblasts were treated with lactosylceramide or the glucocerebrosidase inhibitor conduritol B epoxide. Furthermore, apoA-I-mediated cholesterol efflux from fibroblasts derived from patients with genetic GSL storage diseases (Fabry disease, Sandhoff disease, and GM1 gangliosidosis) was impaired compared with control cells. Conversely, apoA-I-mediated cholesterol efflux from fibroblasts and cholesterol-loaded macrophage foam cells was dose-dependently stimulated (by up to 6-fold over 8 h) by the GSL synthesis inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP). Unexpectedly, a structurally unrelated GSL synthesis inhibitor, N-butyldeoxynojirimycin, was unable to stimulate apoA-I-mediated cholesterol efflux despite achieving similar GSL depletion. PDMP was found to up-regulate ABCA1 mRNA and protein expression, thereby identifying a contributing mechanism for the observed acceleration of cholesterol efflux to apoA-I. This study reveals a novel defect in cellular cholesterol homeostasis induced by GSL storage and identifies PDMP as a new agent for enhancing cholesterol efflux via the ABCA1/apoA-I pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m413862200

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1 Cellular GSL accumulation inhibits apoA-I-mediated cholesterol efflux. Control human fibroblasts ( A and B ) and SLSD fibroblasts ( C ) were grown in medium containing 0.2 𝛍 Ci/ml [ 3 H]cholesterol and 10% FCS for 72 h. After the initial 24 h, either 40 𝛍 M LacCer ( A ) or 50 𝛍 M CBE ( B ) was added as described under 'Experimental Procedures.' After equilibration (in the presence of LacCer or CBE where appropriate), cells were incubated in DMEM containing 0.1% (w/v) BSA or in the same medium with the addition of 25 𝛍 g/ml apoA-I. Aliquots of the media were removed at times up to 8 h, and the percent cholesterol efflux was calculated by dividing [ 3 H]cholesterol released to the medium by the total [ 3 H]cholesterol in the cells after equilibration ( t = 0 h). A : f , BSA; H18554 , BSA + LacCer; ● , apoA-I; E , apoA-I + LacCer. B and C : white bars , BSA; black bars , apoA-I. Con , control, Sand , Sandhoff disease. Values are the means ± S.E. from triplicate cultures of a single experiment, representative of three. *, p < 0.05; **, p < 0.01 (significantly different from apoA-I-dependent cholesterol efflux under control conditions).
FIG. 1 Cellular GSL accumulation inhibits apoA-I-mediated cholesterol efflux. Control human fibroblasts ( A and B ) and SLSD fibroblasts ( C ) were grown in medium containing 0.2 𝛍 Ci/ml [ 3 H]cholesterol and 10% FCS for 72 h. After the initial 24 h, either 40 𝛍 M LacCer ( A ) or 50 𝛍 M CBE ( B ) was added as described under 'Experimental Procedures.' After equilibration (in the presence of LacCer or CBE where appropriate), cells were incubated in DMEM containing 0.1% (w/v) BSA or in the same medium with the addition of 25 𝛍 g/ml apoA-I. Aliquots of the media were removed at times up to 8 h, and the percent cholesterol efflux was calculated by dividing [ 3 H]cholesterol released to the medium by the total [ 3 H]cholesterol in the cells after equilibration ( t = 0 h). A : f , BSA; H18554 , BSA + LacCer; ● , apoA-I; E , apoA-I + LacCer. B and C : white bars , BSA; black bars , apoA-I. Con , control, Sand , Sandhoff disease. Values are the means ± S.E. from triplicate cultures of a single experiment, representative of three. *, p < 0.05; **, p < 0.01 (significantly different from apoA-I-dependent cholesterol efflux under control conditions).CC-BY · From the PDF
FIG. 2 Influence of LacCer on fibroblast phospholipid efflux to apoA-I and cholesterol efflux to apoA-I, PLVs, or MBCD. A , fibroblasts were grown as described in the legend to Fig. 1 and treated with 40 𝛍 M LacCer as indicated prior to analysis of [ 3 H]cholesterol and 3 H-phospholipid efflux to apoA-I as described under 'Experimental Procedures.' B , [ 3 H]cholesterol efflux to PLVs (200 𝛍 g/ml total phospholipid) or MBCD (250 𝛍 M) was also assessed. Data were derived after 8 h of efflux. Values represent the means ± S.E. from triplicate determinations. **, p < 0.01 (significantly different from cells treated with apoA-I alone). Con , control.
FIG. 2 Influence of LacCer on fibroblast phospholipid efflux to apoA-I and cholesterol efflux to apoA-I, PLVs, or MBCD. A , fibroblasts were grown as described in the legend to Fig. 1 and treated with 40 𝛍 M LacCer as indicated prior to analysis of [ 3 H]cholesterol and 3 H-phospholipid efflux to apoA-I as described under 'Experimental Procedures.' B , [ 3 H]cholesterol efflux to PLVs (200 𝛍 g/ml total phospholipid) or MBCD (250 𝛍 M) was also assessed. Data were derived after 8 h of efflux. Values represent the means ± S.E. from triplicate determinations. **, p < 0.01 (significantly different from cells treated with apoA-I alone). Con , control.CC-BY · From the PDF
FIG. 3 Influence of LacCer on fibroblast ABCA1 protein expression. Fibroblasts were grown in DMEM and 10% FCS and treated with 40 𝛍 M LacCer as indicated. Whole cell ( A ) and cell-surface ( B ) ABCA1 levels were assessed by Western blotting as described under 'Experimental Procedures.' Equal amounts of total protein were added to each lane of the polyacrylamide gels. The blots were also stripped and reprobed for 𝛃 -actin or SR-BI ( SRB1 ) as indicated. The integrated optical density ( I.O.D. ) of the bands was measured, and ABCA1 expression is represented graphically relative to 𝛃 -actin (for whole cell) or SR-BI (for cell surface). Con , control.
FIG. 3 Influence of LacCer on fibroblast ABCA1 protein expression. Fibroblasts were grown in DMEM and 10% FCS and treated with 40 𝛍 M LacCer as indicated. Whole cell ( A ) and cell-surface ( B ) ABCA1 levels were assessed by Western blotting as described under 'Experimental Procedures.' Equal amounts of total protein were added to each lane of the polyacrylamide gels. The blots were also stripped and reprobed for 𝛃 -actin or SR-BI ( SRB1 ) as indicated. The integrated optical density ( I.O.D. ) of the bands was measured, and ABCA1 expression is represented graphically relative to 𝛃 -actin (for whole cell) or SR-BI (for cell surface). Con , control.CC-BY · From the PDF
FIG. 4 Expression of ABCA1 mRNA and acyl-CoA:cholesterol acyltransferase-accessible cholesterol in fibroblasts derived from normal subjects and patients with Fabry disease, Sandhoff disease, or GM1 gangliosidosis. A , fibroblasts were grown in DMEM and 10% FCS until confluent and washed three times with PBS; the RNA was extracted; and ABCA1 mRNA was quantified by real-time PCR. B , fibroblasts were labeled with [ 3 H]cholesterol as described in the legend to Fig. 1, and the cholesterol and cholesteryl ester fractions were isolated by TLC. Where indicated, control ( Con ) fibroblasts were also treated with 40 𝛍 M LacCer. The cellular cholesteryl ester content is expressed as a percentage of the total cholesterol. Values are relative to control cells and represent the means ± S.E. from triplicate determinations. **, p < 0.01; ***, p < 0.001 (significantly different from control cells). amt. , amount; Sand , Sandhoff disease.
FIG. 4 Expression of ABCA1 mRNA and acyl-CoA:cholesterol acyltransferase-accessible cholesterol in fibroblasts derived from normal subjects and patients with Fabry disease, Sandhoff disease, or GM1 gangliosidosis. A , fibroblasts were grown in DMEM and 10% FCS until confluent and washed three times with PBS; the RNA was extracted; and ABCA1 mRNA was quantified by real-time PCR. B , fibroblasts were labeled with [ 3 H]cholesterol as described in the legend to Fig. 1, and the cholesterol and cholesteryl ester fractions were isolated by TLC. Where indicated, control ( Con ) fibroblasts were also treated with 40 𝛍 M LacCer. The cellular cholesteryl ester content is expressed as a percentage of the total cholesterol. Values are relative to control cells and represent the means ± S.E. from triplicate determinations. **, p < 0.01; ***, p < 0.001 (significantly different from control cells). amt. , amount; Sand , Sandhoff disease.CC-BY · From the PDF
FIG. 5 HPLCanalysis of SLSD fibroblast GSLs and correlation with cholesterol efflux to apoA-I. A , fibroblasts were grown in DMEM and 10% FCS until confluent; the GSL fractions were isolated from samples containing equal protein concentrations; and the GSLderived glycans were fluorescently labeled with 2-aminobenzamide ( 2AB ) and analyzed by normal phase HPLC as described under 'Experimental Procedures.' The top chromatogram represents a dextran ladder with glucose units given above each peak. CTH , ceramide trihexoside; Con , control. Note that the fluorescence sensitivity during the 60-100-min time frame was increased 5-fold relative to the 20-60-min time frame in all GSL chromatograms. B , total GSL levels expressed relative to the control cells (assigned a value of 1) are plotted against 8-h apoA-I efflux data derived from Fig. 1 C . Point a , Sandhoff disease; point b , GM1 gangliosidosis; point c , Fabry disease; point d , control.
FIG. 5 HPLCanalysis of SLSD fibroblast GSLs and correlation with cholesterol efflux to apoA-I. A , fibroblasts were grown in DMEM and 10% FCS until confluent; the GSL fractions were isolated from samples containing equal protein concentrations; and the GSLderived glycans were fluorescently labeled with 2-aminobenzamide ( 2AB ) and analyzed by normal phase HPLC as described under 'Experimental Procedures.' The top chromatogram represents a dextran ladder with glucose units given above each peak. CTH , ceramide trihexoside; Con , control. Note that the fluorescence sensitivity during the 60-100-min time frame was increased 5-fold relative to the 20-60-min time frame in all GSL chromatograms. B , total GSL levels expressed relative to the control cells (assigned a value of 1) are plotted against 8-h apoA-I efflux data derived from Fig. 1 C . Point a , Sandhoff disease; point b , GM1 gangliosidosis; point c , Fabry disease; point d , control.CC-BY · From the PDF
FIG. 6 Depletion of fibroblast GSLs by PDMP as assessed by fluorescent CTxB binding to GM1. Fibroblasts were grown in medium containing 0-40 𝛍 M PDMP in DMEM and 10% FCS for 72 h. Cells were then washed and equilibrated overnight in DMEM containing 0.1% (w/v) BSA and PDMP where appropriate. The binding of fluorescently labeled CTxB to cell-surface GM1 was assessed as described under 'Experimental Procedures.' Values are the means ± S.E. from triplicate cultures, where binding in the absence of PDMP was taken to be 100%.
FIG. 6 Depletion of fibroblast GSLs by PDMP as assessed by fluorescent CTxB binding to GM1. Fibroblasts were grown in medium containing 0-40 𝛍 M PDMP in DMEM and 10% FCS for 72 h. Cells were then washed and equilibrated overnight in DMEM containing 0.1% (w/v) BSA and PDMP where appropriate. The binding of fluorescently labeled CTxB to cell-surface GM1 was assessed as described under 'Experimental Procedures.' Values are the means ± S.E. from triplicate cultures, where binding in the absence of PDMP was taken to be 100%.CC-BY · From the PDF
FIG. 7 PDMP promotes apoA-I dependent-cholesterol and phospholipid efflux. Fibroblasts were grown in DMEM containing [ 3 H]cholesterol or [ 3 H]choline, 10% FCS, and 10 𝛍 M PDMP as indicated for 72 h. Cells were then washed, equilibrated (in the presence of PDMP where appropriate), and incubated in DMEM containing 0.1% (w/v) BSA or in the same medium with the addition of 25 𝛍 g/ml apoA-I. Aliquots of the media were removed at the indicated times, and the percent cholesterol and phospholipid efflux was calculated as described in the legend to Fig. 1. Values are the means ± S.E. from triplicate cultures, representative of seven experiments. ● , apoA-I; E , apoA-I + 10 𝛍 M PDMP; f , BSA; H18554 , BSA + 10 𝛍 M PDMP.
FIG. 7 PDMP promotes apoA-I dependent-cholesterol and phospholipid efflux. Fibroblasts were grown in DMEM containing [ 3 H]cholesterol or [ 3 H]choline, 10% FCS, and 10 𝛍 M PDMP as indicated for 72 h. Cells were then washed, equilibrated (in the presence of PDMP where appropriate), and incubated in DMEM containing 0.1% (w/v) BSA or in the same medium with the addition of 25 𝛍 g/ml apoA-I. Aliquots of the media were removed at the indicated times, and the percent cholesterol and phospholipid efflux was calculated as described in the legend to Fig. 1. Values are the means ± S.E. from triplicate cultures, representative of seven experiments. ● , apoA-I; E , apoA-I + 10 𝛍 M PDMP; f , BSA; H18554 , BSA + 10 𝛍 M PDMP.CC-BY · From the PDF
FIG. 8 PDMP does not promote cholesterol efflux to PLVs or MBCD. Fibroblasts were grown in DMEM containing [ 3 H]cholesterol and 10% FCS or in the same medium supplemented with 10 𝛍 M PDMP ( cross-hatched ) for 72 h. Cells were then washed, equilibrated (in the presence of PDMP where appropriate), and incubated in DMEM containing 0.1% (w/v) BSA or in the same medium with the addition of 25 𝛍 g/ml apoA-I. Cholesterol efflux in the presence of PLVs ( A ) or MBCD ( B ) was also assessed. Aliquots of the media were removed after 8 h, and the percent cholesterol efflux was calculated as described in the legend to Fig. 1. Values are the means ± S.E. from triplicate cultures, representative of two experiments for each condition. Con , control.
FIG. 8 PDMP does not promote cholesterol efflux to PLVs or MBCD. Fibroblasts were grown in DMEM containing [ 3 H]cholesterol and 10% FCS or in the same medium supplemented with 10 𝛍 M PDMP ( cross-hatched ) for 72 h. Cells were then washed, equilibrated (in the presence of PDMP where appropriate), and incubated in DMEM containing 0.1% (w/v) BSA or in the same medium with the addition of 25 𝛍 g/ml apoA-I. Cholesterol efflux in the presence of PLVs ( A ) or MBCD ( B ) was also assessed. Aliquots of the media were removed after 8 h, and the percent cholesterol efflux was calculated as described in the legend to Fig. 1. Values are the means ± S.E. from triplicate cultures, representative of two experiments for each condition. Con , control.CC-BY · From the PDF
FIG. 9 Effect of PDMP on fibroblast ABCA1 mRNA and protein expression. Fibroblasts were grown in DMEM and 10% FCS or the same medium supplemented with either 2.5 or 10 𝛍 M PDMP for 72 h. Cells were then washed and equilibrated (in the presence of PDMP where appropriate) for 16 h. The cells were extracted into TriReagent for ABCA1 mRNA analysis by real-time PCR ( A ) or processed for whole cell ( B ) and cell-surface ( C ) ABCA1 analyses by Western blotting as described under 'Experimental Procedures.' Values are the means ± S.E. from triplicate cultures, representative of five ( A ) and two ( B and C ) experiments. Data are for relative expression levels, where controls ( Con ; no PDMP) were assigned a value of 1 ( B ), or, in the case of cell-surface ABCA1, are corrected for SR-BI ( SRB1 ) levels ( C ). *, p < 0.05 (significantly different from control conditions). amt. , amount; I.O.D., integrated optical density.
FIG. 9 Effect of PDMP on fibroblast ABCA1 mRNA and protein expression. Fibroblasts were grown in DMEM and 10% FCS or the same medium supplemented with either 2.5 or 10 𝛍 M PDMP for 72 h. Cells were then washed and equilibrated (in the presence of PDMP where appropriate) for 16 h. The cells were extracted into TriReagent for ABCA1 mRNA analysis by real-time PCR ( A ) or processed for whole cell ( B ) and cell-surface ( C ) ABCA1 analyses by Western blotting as described under 'Experimental Procedures.' Values are the means ± S.E. from triplicate cultures, representative of five ( A ) and two ( B and C ) experiments. Data are for relative expression levels, where controls ( Con ; no PDMP) were assigned a value of 1 ( B ), or, in the case of cell-surface ABCA1, are corrected for SR-BI ( SRB1 ) levels ( C ). *, p < 0.05 (significantly different from control conditions). amt. , amount; I.O.D., integrated optical density.CC-BY · From the PDF
FIG. 10 Effect of PDMP on Triton-soluble and Triton-insoluble cholesterol distribution. A , fibroblasts were grown in DMEM and 10% FCS with 0.2 mCi/ml [ 3 H]cholesterol ( 3H-Chol. ) or the same medium supplemented with 2.5, 10, or 40 𝛍 M PDMP for 72 h. Cells were then washed and equilibrated (in the presence of PDMP where appropriate) for 16 h. The cells were extracted into cold Triton X-100, and the detergent-insoluble ( Insol. ; ● ) and detergent-soluble ( Sol. ; E ) cholesterol levels were measured as described under 'Experimental Procedures.' B , the data are expressed as percent insoluble cholesterol. Values are the means ± S.E. from triplicate cultures. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (significantly different from control conditions).
FIG. 10 Effect of PDMP on Triton-soluble and Triton-insoluble cholesterol distribution. A , fibroblasts were grown in DMEM and 10% FCS with 0.2 mCi/ml [ 3 H]cholesterol ( 3H-Chol. ) or the same medium supplemented with 2.5, 10, or 40 𝛍 M PDMP for 72 h. Cells were then washed and equilibrated (in the presence of PDMP where appropriate) for 16 h. The cells were extracted into cold Triton X-100, and the detergent-insoluble ( Insol. ; ● ) and detergent-soluble ( Sol. ; E ) cholesterol levels were measured as described under 'Experimental Procedures.' B , the data are expressed as percent insoluble cholesterol. Values are the means ± S.E. from triplicate cultures. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (significantly different from control conditions).CC-BY · From the PDF
FIG. 11 Effect of NB-DNJ on fibroblast GSL levels, cholesterol solubility, and apoA-I-mediated cholesterol efflux. A , fibroblasts were grown in DMEM and 10% FCS with [ 3 H]cholesterol ( 3H-Chol. ) or [ 3 H]choline in the presence of 50 𝛍 M NB-DNJ ( cross-hatched ) as indicated for 72 h. Cells were then washed and equilibrated (in the presence of NB-DNJ where appropriate) for 16 h. The cells were assayed for cell-surface GM1 expression by CTxB binding, Triton X-100-insoluble cholesterol ( TX-100 ), or 8-h [ 3 H]cholesterol efflux in DMEM containing 0.1% (w/v) BSA (control ( Con )) or in the same medium with the addition of 25 𝛍 g/ml apoA-I as described under 'Experimental Procedures.' B , the effect of NB-DNJ on phospholipid efflux to apoA-I was analyzed. Values are the means ± S.E. from triplicate cultures, representative of two experiments, p < 0.05; ***, p < 0.01 (significantly different from parallel conditions without NB-DNJ treatment).
FIG. 11 Effect of NB-DNJ on fibroblast GSL levels, cholesterol solubility, and apoA-I-mediated cholesterol efflux. A , fibroblasts were grown in DMEM and 10% FCS with [ 3 H]cholesterol ( 3H-Chol. ) or [ 3 H]choline in the presence of 50 𝛍 M NB-DNJ ( cross-hatched ) as indicated for 72 h. Cells were then washed and equilibrated (in the presence of NB-DNJ where appropriate) for 16 h. The cells were assayed for cell-surface GM1 expression by CTxB binding, Triton X-100-insoluble cholesterol ( TX-100 ), or 8-h [ 3 H]cholesterol efflux in DMEM containing 0.1% (w/v) BSA (control ( Con )) or in the same medium with the addition of 25 𝛍 g/ml apoA-I as described under 'Experimental Procedures.' B , the effect of NB-DNJ on phospholipid efflux to apoA-I was analyzed. Values are the means ± S.E. from triplicate cultures, representative of two experiments, p < 0.05; ***, p < 0.01 (significantly different from parallel conditions without NB-DNJ treatment).CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Research works printed but not linked: 1

  1. Radin, 1993, Adv. Lipid Res., 26, 183

Cited by

See all 76

Metadata

Authors
Glaros, E. N., Kim, W. S., Quinn, C. M., Wong, J., Gelissen, I., Jessup, W., & Garner, B.
Affiliations
UNSW Sydney (AU)
Corresponding author
Garner, Brett
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2005-07
Volume
280
Issue
26
Pages
24515-24523
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2134647594
Cited by
75
References
61
Citations by year
2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 7 · 2014: 6 · 2013: 6 · 2012: 4
FWCI
5.39
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Online (University of Wollongong) (submittedVersion)
  • Figshare (submittedVersion)
Funders
  • National Heart Foundation of Australia (222722)
  • Medical Research Council
  • National Health and Medical Research Council (350810)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords
cholesterol efflux, ABCA1, apolipoprotein A-I, lactosylceramide, conduritol B epoxide, glucocerebrosidase, Fabry disease, Sandhoff disease, GM1 gangliosidosis, prescription drug monitoring programs, N-butyldeoxynojirimycin, cholesterol homeostasis, foam cells, fibroblasts
MeSH terms
Cell Line, Cell Membrane, Cholesterol, Chromatography, High Pressure Liquid, Dose-Response Relationship, Drug, Enzyme Inhibitors, Fibroblasts, Glycosphingolipids, Humans, Lactosylceramides, Lipoproteins, LDL, Monocytes, Morpholines, Phospholipids, RNA, Messenger, Time Factors, Blotting, Western, Antigens, CD, Up-Regulation, Apolipoprotein A-I, 1-Deoxynojirimycin, ATP-Binding Cassette Transporters, Biotinylation, Reverse Transcriptase Polymerase Chain Reaction, ATP Binding Cassette Transporter 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway. https://app.cochat.ai/papers/10.1074/jbc.m413862200
The paper
Glaros, E. N., Kim, W. S., Quinn, C. M., Wong, J., Gelissen, I., Jessup, W., & Garner, B. (2005). Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m413862200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.